SIC
DPLO

Salem Investment Counselors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Salem Investment Counselors’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,525
Closed -$23K – 693
2017
Q2 		$23K Hold
1,525
– – ﹤0.01% 388
2017
Q1 		$24K Hold
1,525
– – ﹤0.01% 452
2016
Q4 		$19K Buy
+1,525
New +$28.4K ﹤0.01% 447

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Salem Investment Counselors's DPLO Position: Q3 2017 in Review

Salem Investment Counselors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2017, closing a stake of 1,525 shares — an estimated $23K sold.

Salem Investment Counselors first reported a position in DPLO in Q4 2016 and held it in 3 quarters. The position peaked at $24K in Q1 2017. 165 funds tracked by Wall St. Rank hold DPLO as of Q3 2017.

  • Salem Investment Counselors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2017 after selling out during the quarter.
  • Salem Investment Counselors sold 1,525 DIPLOMAT PHARMACY, INC. shares in Q3 2017, an estimated $23K.
  • Salem Investment Counselors first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2016 and held it in 3 quarters.
  • Salem Investment Counselors's DIPLOMAT PHARMACY, INC. position peaked at $24K in Q1 2017.
  • 165 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2017.

Based on Salem Investment Counselors's 13F filing for Q3 2017, filed 16 Nov 2017.